Today the JNM Podcast is tackling an in-depth and technical topic: FDA approval pathways for new versions of current radiopharmaceuticals. Often called equivalents, the hope is that these “new” drugs can be expedited to the market by taking the same approval pathway of older, but similar versions. Joining host Ken Herrmann to help navigate these regulatory frameworks are two experts: Tom Hope, MD, and Aman Chauhan, MD. Tune in wherever you stream podcasts! 

The NCI Cancer Therapy Evaluation Program (CTEP) Investigational Drug Branch (IDB) offers a no-cost, 4 to 8-week externship at the NCI Shady Grove Campus in Rockville, MD. (https://dctd.cancer.gov/programs/ctep)

Key Details

• Target Audience: Medical/radiation oncology fellows or junior faculty (within 7 years of training completion).
• Focus: Participants shadow IDB Medical Officers, observe trial development, and learn to write Letters of Intent (LOIs).
• Logistics: Participants are responsible for their own room, board, and travel expenses.
• Application: Space is limited to 4 participants per month, with inquiries handled through the ETCTN CRDL Program. 

Thank you to Curium for sponsoring this episode. https://www.curiumpharma.com/